February 20, 2020 | posted by Leo Lens
Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]
November 12, 2019 | posted by Leo Lens
FOR IMMEDIATE RELEASE Leo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product Awards Unique Drug Delivery Contact Lens Product is a Finalist in the Life Sciences & Healthtech Category SAN DIEGO, CA, USA (NOVEMBER 11, 2019) – Today, Leo Lens Technology announced that its unique drug delivery contact lens product has […]
September 5, 2019 | posted by Leo Lens
Leo Lens was featured in a Member Spotlight article from Biocom. Read it here: https://www.biocom.org/corporate-newsletter/newsletter-article/?article=Biocom-Member-Spotlight-Interview-with-Kokila-and-Praful-Doshi-Co-Founders-of-Leo-Lens-Technology
October 10, 2018 | posted by Leo Lens
Leo Lens was selected from over 150 companies to be a presenting company at Octane’s 2018 Medical Technology Innovation Forum. For more information on the event go to www.mtif2018.com.